T-5224, a selective inhibitor of c-Fos/activator protein-1, improves survival by inhibiting serum high mobility group box-1 in lethal lipopolysaccharide-induced acute kidney injury model

MLA

Mari Ishida, et al. “T-5224, a Selective Inhibitor of c-Fos/Activator Protein-1, Improves Survival by Inhibiting Serum High Mobility Group Box-1 in Lethal Lipopolysaccharide-Induced Acute Kidney Injury Model.” Journal of Intensive Care, vol. 3, Nov. 2015. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59b206a72795e3b200968c1d02b946c6&authtype=sso&custid=ns315887.

APA

Mari Ishida, Shunichi Shiozawa, Masaaki Ueki, Masaki Ueno, Jun Morishita, & Nobuhiro Maekawa. (2015). T-5224, a selective inhibitor of c-Fos/activator protein-1, improves survival by inhibiting serum high mobility group box-1 in lethal lipopolysaccharide-induced acute kidney injury model. Journal of Intensive Care, 3.

Chicago

Mari Ishida, Shunichi Shiozawa, Masaaki Ueki, Masaki Ueno, Jun Morishita, and Nobuhiro Maekawa. 2015. “T-5224, a Selective Inhibitor of c-Fos/Activator Protein-1, Improves Survival by Inhibiting Serum High Mobility Group Box-1 in Lethal Lipopolysaccharide-Induced Acute Kidney Injury Model.” Journal of Intensive Care 3 (November). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....59b206a72795e3b200968c1d02b946c6&authtype=sso&custid=ns315887.